Forster Seth P, Lebo David B
Pharmaceutical Commercialization Technology, MMD, Merck & Co., Inc., Kenilworth, NJ 07033, USA.
Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, PA 19140, USA.
Pharmaceutics. 2021 Jun 11;13(6):863. doi: 10.3390/pharmaceutics13060863.
Taste-masking of drugs, particularly to produce formulations for pediatric patients, can be challenging and require complex manufacturing approaches. The objective of this study was to produce taste-masked ibuprofen granules using a novel process, twin-screw melt granulation (TSMG). TSMG is an emerging, high-productivity, continuous process. Granules of ibuprofen embedded in a lipid matrix were produced across a range of process conditions, resulting in a range of output granule particle sizes. The ibuprofen appeared to be miscible with the lipid binder though it recrystallized after processing. The ibuprofen melt granules were tested in simulated saliva using a novel, small-volume dissolution technique with continuous acquisition of the ibuprofen concentration. The ibuprofen release from the granules was slower than the neat API and physical blend, beyond the expected residence time of the granules in the mouth. The ibuprofen release was inversely related to the granule size. A Noyes-Whitney dissolution model was used and the resulting dissolution rate constants correlated well with the granule size.
药物的掩味,尤其是制备儿科患者用制剂,可能具有挑战性且需要复杂的制造方法。本研究的目的是采用一种新型工艺——双螺杆熔融制粒(TSMG)来制备掩味布洛芬颗粒。TSMG是一种新兴的、高生产率的连续工艺。在一系列工艺条件下制备了包埋于脂质基质中的布洛芬颗粒,得到了一系列不同粒径的产出颗粒。布洛芬似乎与脂质粘合剂可混溶,不过在加工后会重结晶。使用一种新型的小体积溶出技术并连续采集布洛芬浓度,在模拟唾液中对布洛芬熔融颗粒进行了测试。布洛芬从颗粒中的释放比纯原料药和物理混合物慢,超过了颗粒在口腔中的预期停留时间。布洛芬的释放与颗粒大小呈负相关。使用了诺伊斯 - 惠特尼溶出模型,所得的溶出速率常数与颗粒大小相关性良好。